Professional Documents
Culture Documents
Vaccination Data and Research in Lmic Dadari Psi 23rd July
Vaccination Data and Research in Lmic Dadari Psi 23rd July
Vaccination Data and Research in Lmic Dadari Psi 23rd July
research opportunities in
low- & middle-income
countries
23 July 2022
OUTLINE
➢ Basics of Vaccination
➢ Sources of Vaccination Data & Description
➢ 2021 WUENIC
➢ 2021 PAPA LQAS
➢ 2021 MICS_NICS
➢ Research Opportunities
BASICS OF VACCINATION
Vaccination is the act of introducing a vaccine into the body to produce protection from a specific disease or the
administration of a vaccine to help the immune system develop immunity from a disease.
Vaccines contain a part or whole microorganism or virus in a weakened, live or killed state, or proteins or toxins
from the organism.
Herd immunity is achieved when a sufficiently large percentage of a population are vaccinated and depends on
factors such as the virulence and infectivity of the pathogen.
Herd immunity provides protection to those who may be immunocompromised and cannot get a vaccine
because even a weakened version would harm them
Target population for childhood vaccination is the estimated newborn population and, or surviving infant for that
locality
Zero-dose children are those that have not received any routine vaccine. For operational purposes, Gavi defines zero-
dose children based on lack of the first dose of diphtheria-tetanus-pertussis containing vaccine (DTPcv1).
Under-immunised are those who have not received a full course of routine vaccines. For operational purposes, Gavi
defines under-immunised children as those missing a third dose of diphtheria-tetanus-pertussis containing vaccine.
Missed communities are home to clusters of zero-dose and underimmunised children, even before the COVID-19
pandemic. These communities often face multiple deprivations and vulnerabilities, including lack of services, socio-
economic inequities and often gender related barriers.
Equity: The organising principle of the Alliance’s 2021-2025 strategy, whose vision is Leaving no-one behind with
Immunisation. This entails a laser focus on using all Gavi levers to reach missed communities and zero-dose children with
immunisation.
NIGERIA EPI SCHEDULE
Child Age Vaccination Schedule
Birth BCG HepB_Pediatric OPV
6 weeks Pneumo_conj DTwPHibHepB OPV Rotavirus
6 months VitaminA
9 months Yellow Fever Measles MenA_conj
12 months VitaminA
15 months Measles
PRINCIPAL SOURCES OF VACCINATION DATA FOR MONITORING AND
DECISION MAKING
Surveys
Demographic and Health Surveys (DHS)
Multiple Indicator Cluster Surveys (MICS)
National (Subnational) Immunization Coverage Surveys (NICS)
WUENIC
WUENIC 2022
The number of zero-dose children increased sharply during the
2020-2021 pandemic years The number of zero-dose
An additional 5m zero-dose children from 2019 children – those never
vaccinated with a first dose of
DTP-containing vaccine,
increased by 37%, from 13 to
18 million between 2019-2021.
18 million children were left out by
immunization services in 2021, a
number not seen since 2005.
Almost all zero-dose children live in
low- and middle-income countries,
with global share of zero-dose
children distributed as such:
WUENIC 2022
Just 10 countries account for
Countries with the most unprotected children in 2021 62% of zero-dose children.
Roughly the same countries
also account for 59% of the
children missing out on a
measles vaccine.
WUENIC 2022
Countries with most
Just 10 countries account for 59% of children who missed the first unprotected children
dose of a measles vaccine 10 countries account for 14.6 of the
24.7 million children who missed a
Millions of children lacking a single dose of measles containing vaccine. first dose of measles vaccine in the
- 0.5 1.0 1.5 2.0 2.5 3.0 3.5 world (59%). This list includes some
countries with moderate coverage
Nigeria, 41% 3.1 and very large birth cohorts, and
other countries with substantially
India, 11% 2.5 lower coverage.
All the LGAs in the 36 states plus FCT except 3 LGAs in Borno, 1 LGA in Kaduna and 1 LGA in Niger states were surveyed.
In each LGA, 6 HFs were selected using Probability Proportional to Size (PPS)
In each HF, 6 settlements were selected using PPS.
In each settlement, 10 households were randomly selected.
In each household, a child 0-11 months with the mother were randomly selected.
Assessment of the RI activities in 18 NERICC priority States in Nigeria
Settlement
House 1 House 2 House 3 House 4 House 5 House 6 House 7 House 8 House 9 House 10
Child 1 Child 2 Child 3 Child 4 Child 5 Child 6 Child 7 Child 8 Child 9 Child 10
= ONE CLUSTER 20
RI LQAS Methods (2)
LQAS data analysis & Interpretation
States = 37
LGAs = 769
HFs = 4,513
Settlements = 4,614
99% (769/774) of the Lots were surveyed; out of which 308 (40%) Lots passed
NPHCDA – National Primary Health Care Development Agency
100%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
68%
Abia 75%
90%
Adamawa 89%
72%
Akwa Ibom 71%
82%
Anambra 85%
77%
Bauchi 85%
66%
Bayelsa 70%
53%
Benue 60%
78%
Borno 85%
72%
Cross River 49%
68%
Delta 79%
75%
Ebonyi 71%
87%
Edo 83%
86%
Ekiti 84%
75%
Enugu 72%
76%
FCT, Abuja 77%
81%
Gombe 85%
83%
Imo 82%
88%
Q4-2020
Jigawa 86%
72%
Kaduna 70%
88%
Kano 86%
68%
Katsina 76%
Card+ History
75%
Kebbi 83%
73%
Kogi 68%
71%
Kwara 68%
Q4-2021
91%
Lagos 92%
79%
Nasarawa 83%
73%
Niger 75%
68%
Ogun 65%
States, PAPA RI LQAS, Q4-2020 vs Q4, 2021
84%
Ondo 83%
NPHCDA – National Primary Health Care Development Agency
83%
Osun 78%
61%
Oyo 66%
69%
Plateau 76%
Proportion of children appropriately immunized for age by
81%
Rivers 81%
70%
Sokoto 56%
70%
Taraba 57%
81%
Yobe 89%
52%
Zamfara 62%
76%
Average 76%
Reason for Partially/Not appropriately immunized for age, Q4, 2021
Note: The designations employed, and the presentation of these materials do not imply the expression of any opinion whatsoever on the part of WHO
concerning the legal status of any country, territory or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed
lines on maps represent approximate border lines for which there may not yet be full agreement.
31 Source: WHO COVID-19 Dashboard (map), UNICEF Procurement Portal (COVAX shipments), Bloomberg (total # of doses administered),
82% of the population of the African Union has not received any Covid-19
vaccine dose as of Feb. 28, 2022
Share of population vaccinated with complete initial protocol Share of population partially vaccinated1
EUR
61% 5% 34% 572 44 315
931M pop
WPR
81% 3% 16% 1,594 57 312
1,964M pop
AMR
65% 11% 24% 662 109 247
1,018M pop
EMR
37% 9% 55% 267 62 396
726M pop
SEAR
55% 13% 32% 1,103 267 651
2,021M pop
AFR 3%
86% 120 37 963
1,120M pop 11%
AU
14% 4% 82% 184 57 1,098
1,339M pop
IA2030 Vision
• A world where everyone, everywhere, at
every age fully benefits from vaccines for
good health and well-being
PHASE 1 SCORECARD
36
Equity Reference Group (ERG)
ERG
The ERG has identified
four priorities of work --
urban poor areas,
remote/rural areas,
children affected by
conflict, and gender-
related inequities and
barriers to
immunization.
https://sites.google.com/view/erg4immunisation/home
GAVI ALLIANCE FRAMEWORK: IDENTIFY, REACH, MONITOR,
MEASURE, AND ADVOCATE (IRMMA)
38
GAVI COUNTRY LEARNING HUBS
Learning hub theory of change (TOC) Illustrative country-level learning hub model
EQUITY LEARNING PRIORITIES
REACH
• What specific approaches are designed
to reach zero-dose children and
IDENTIFY missed communities and to bring them
• Where, who and how many are in to the health system towards full
zero-dose children, and missed immunization? What works well, what
communities? Why are they does not work well and why?
being missed and what are the • What are the key barriers and enabling
root causes? factors at community level to reach
• What are the most effective zero-dose children and to bring them in
approaches and methods to the health system through full
used for identifying zero-dose immunization?
communities? What works well,
what does not work well and
why? MONITOR & MEASURE
• What are the key barriers and • What are the most effective
enabling factors at each level approaches and methods to
(policy to community) to identify ADVOCATE monitor and measure reaching
zero-dose communities? • What strategies are effective in zero-dose, under-immunised
securing and sustaining political will children and missed
across different levels to identify and communities? What works well,
40
reach zero dose populations? what does not work well and why?
• IR approach: work in partnership with
IMPLEMENTATIO decision-makers and implementers in
countries to identify priority implementation
N RESEARCH challenges (and related research
questions) for immunization
• Support in evidence-generation: identify
“The integration of research within and test strategies to overcome
existing health programme implementation bottlenecks and improve
implementation and policymaking systems, explore what works best and what
cycles to improve programme not, suggests optimal pro-equity
outcomes (i.e., coverage, immunization strategies for scaling up
sustainability, efficiency, cost,
scale) and overcome • Support in disseminate of IR findings and
implementation bottlenecks” recommendations and integrate those into
policies and programmes designed to
improve outcomes in zero-dose
communities
Integrating COVID 19 vaccination into Primary Healthcare and
Routine Immunization
Sustainability
01 Current efforts in delivering C19 vaccination are primary through resource-intensive campaigns, with
some level of integration. A shift towards sustainability in vaccination is required.
Life-course approach
02 Current immunization systems are not optimized for adult vaccination, most services are organized
around mother and child vaccination. What needs to be done to include adults and high-risk groups?
Epidemiological challenge
03 Regular boosters will likely be needed for high-risk groups.
Leveraging resources
04 Resource levels now available for C19 response can be utilized to strengthen systems. How can we
leverage existing opportunities and financing?
A NETWORK OF ORGANIZATIONS ALIGNING, COORDINATING AND
CATALYSING ZERO DOSE LEARNING & RESEARCH
Catalytic functions
• Alliance roles
(guidance, technical,
capacity)
• Generate/synthesize
additional learning
• Global learning
networks
• Other technical and
capacity support
• Southern/regional
technical, learning, and
capacity networks
SOME RESOURCES
Equity Reference Group for Immunization. https://sites.google.com/view/erg4immunisation/home
Immunization Agenda 2030: A Global Strategy to Leave No One Behind. https://www.who.int/teams/immunization-vaccines-and-
biologicals/strategies/ia2030
Immunization country profiles. https://data.unicef.org/resources/immunization-country-profiles/
Immunization: The Basics. https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm
The Zero-Dose Child: Explained. https://www.gavi.org/vaccineswork/zero-dose-child-explained
Multiple Indicator Cluster Survey (MICS). https://mics.unicef.org/
Demographic and Health Survey (DHS). https://dhsprogram.com/Methodology/Survey-
Types/DHS.cfm#:~:text=Demographic%20and%20Health%20Surveys%20(DHS,population%2C%20health%2C%20and%20nutrition.
District Health Information Software (DHIS). https://dhis2.org/
Country/territory research output table. (n.d.). Nature Index. https://www.natureindex.com/country-outputs/generate/All/global
THANK YOU!